Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,379
Closed -$227K 655
2025
Q1
$227K Buy
+1,379
New +$229K 0.02% 500
2024
Q4
Sell
-1,539
Closed -$301K 642
2024
Q3
$301K Sell
1,539
-87
-5% -$16K 0.03% 438
2024
Q2
$282K Buy
+1,626
New +$271K 0.03% 435
2024
Q1
Sell
-1,107
Closed -$219K 617
2023
Q4
$219K Buy
+1,107
New +$196K 0.03% 504
2023
Q1
Sell
-1,563
Closed -$229K 659
2022
Q4
$229K Sell
1,563
-484
-24% -$71.6K 0.03% 483
2022
Q3
$304K Sell
2,047
-993
-33% -$166K 0.04% 401
2022
Q2
$523K Sell
3,040
-1,743
-36% -$301K 0.07% 308
2022
Q1
$902K Sell
4,783
-1,357
-22% -$268K 0.09% 240
2021
Q4
$1.5M Buy
6,140
+760
+14% +$166K 0.14% 159
2021
Q3
$1.04M Buy
5,380
+1,652
+44% +$333K 0.11% 204
2021
Q2
$695K Buy
3,728
+90
+2% +$15.6K 0.08% 271
2021
Q1
$573K Buy
3,638
+185
+5% +$29.3K 0.07% 284
2020
Q4
$571K Buy
3,453
+536
+18% +$87.2K 0.08% 256
2020
Q3
$482K Buy
2,917
+5
+0.2% +$768 0.09% 230
2020
Q2
$399K Buy
2,912
+143
+5% +$18.7K 0.08% 256
2020
Q1
$326K Buy
2,769
+881
+47% +$116K 0.08% 272
2019
Q4
$250K Buy
+1,888
New +$235K 0.04% 402

Other funds holding ZTS

Kovack Advisors's ZTS Position: Q2 2025 in Review

Kovack Advisors sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 1,379 shares — an estimated $227K sold.

Kovack Advisors first reported a position in ZTS in Q4 2019 and held it in 17 quarters. The position peaked at $1.5M in Q4 2021. 1,872 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Kovack Advisors reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • Kovack Advisors sold 1,379 Zoetis shares in Q2 2025, an estimated $227K.
  • Kovack Advisors first reported a position in Zoetis in Q4 2019 and held it in 17 quarters.
  • Kovack Advisors's Zoetis position peaked at $1.5M in Q4 2021.
  • 1,872 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Kovack Advisors's 13F filing for Q2 2025, filed 4 Aug 2025.